Biologically active secondary metabolites from Actinomycetes

被引:110
作者
Solecka, Jolanta [1 ]
Zajko, Joanna [1 ]
Postek, Magdalena [1 ]
Rajnisz, Aleksandra [1 ]
机构
[1] Natl Inst Hyg, Natl Inst Publ Hlth, Lab Biologically Act Cpds, PL-00791 Warsaw, Poland
来源
CENTRAL EUROPEAN JOURNAL OF BIOLOGY | 2012年 / 7卷 / 03期
关键词
Bioactive; Secondary metabolites; Antibacterial properties; Cytotoxicity; Streptomyces sp; DD-CARBOXYPEPTIDASE INHIBITOR; MARINE ACTINOMYCETE; NATURAL-PRODUCTS; ANTIBACTERIAL ACTIVITY; MACROLIDE ANTIBIOTICS; GENOME SEQUENCE; DRUG DISCOVERY; GENE-CLUSTER; A-D; STREPTOMYCES;
D O I
10.2478/s11535-012-0036-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Secondary metabolites obtained from Actinomycetales provide a potential source of many novel compounds with antibacterial, antitumour, antifungal, antiviral, antiparasitic and other properties. The majority of these compounds are widely used as medicines for combating multidrug-resistant Gram-positive and Gram-negative bacterial strains. Members of the genus Streptomyces are profile producers of previously-known secondary metabolites. Actinomycetes have been isolated from terrestrial soils, from the rhizospheres of plant roots, and recently from marine sediments. This review demonstrates the diversity of secondary metabolites produced by actinomycete strains with respect to their chemical structure, biological activity and origin. On the basis of this diversity, this review concludes that the discovery of new bioactive compounds will continue to pose a great challenge for scientists.
引用
收藏
页码:373 / 390
页数:18
相关论文
共 113 条
[1]  
Abdalla MA, 2010, NAT PROD COMMUN, V5, P1917
[2]   Dermacozines, a new phenazine family from deep-sea dermacocci isolated from a Mariana Trench sediment [J].
Abdel-Mageed, Wael M. ;
Milne, Bruce F. ;
Wagner, Marcell ;
Schumacher, Marc ;
Sandor, Peter ;
Pathom-aree, Wasu ;
Goodfellow, Michael ;
Bull, Alan T. ;
Horikoshi, Koki ;
Ebel, Rainer ;
Diederich, Marc ;
Fiedler, Hans-Peter ;
Jaspars, Marcel .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (10) :2352-2362
[3]   Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs [J].
Aggarwal, Dimple ;
Fernandez, Maria Luz ;
Soliman, Ghada A. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (06) :794-802
[4]   ADRIAMYCIN, 14-HYDROXYDAUNOMYCIN, A NEW ANTITUMOR ANTIBIOTIC FROM S-PEUCETIUS VAR CAESIUS [J].
ARCAMONE, F ;
CASSINEL.G ;
FANTINI, G ;
GREIN, A ;
OREZZI, P ;
POL, C ;
SPALLA, C .
BIOTECHNOLOGY AND BIOENGINEERING, 1969, 11 (06) :1101-&
[5]   Natural products to drugs: daptomycin and related lipopeptide antibiotics [J].
Baltz, RH ;
Miao, V ;
Wrigley, SK .
NATURAL PRODUCT REPORTS, 2005, 22 (06) :717-741
[6]  
Baltz RH., 2007, MICROBE, V2, P125
[7]   Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) [J].
Bentley, SD ;
Chater, KF ;
Cerdeño-Tárraga, AM ;
Challis, GL ;
Thomson, NR ;
James, KD ;
Harris, DE ;
Quail, MA ;
Kieser, H ;
Harper, D ;
Bateman, A ;
Brown, S ;
Chandra, G ;
Chen, CW ;
Collins, M ;
Cronin, A ;
Fraser, A ;
Goble, A ;
Hidalgo, J ;
Hornsby, T ;
Howarth, S ;
Huang, CH ;
Kieser, T ;
Larke, L ;
Murphy, L ;
Oliver, K ;
O'Neil, S ;
Rabbinowitsch, E ;
Rajandream, MA ;
Rutherford, K ;
Rutter, S ;
Seeger, K ;
Saunders, D ;
Sharp, S ;
Squares, R ;
Squares, S ;
Taylor, K ;
Warren, T ;
Wietzorrek, A ;
Woodward, J ;
Barrell, BG ;
Parkhill, J ;
Hopwood, DA .
NATURE, 2002, 417 (6885) :141-147
[8]   Bioactive microbial metabolites -: A personal view [J].
Bérdy, J .
JOURNAL OF ANTIBIOTICS, 2005, 58 (01) :1-26
[9]   Bagremycin A and B, novel antibiotics from Streptomyces sp Tu 4128 [J].
Bertasso, M ;
Holzenkämpfer, M ;
Zeeck, A ;
Dall'Antonia, F ;
Fiedler, HP .
JOURNAL OF ANTIBIOTICS, 2001, 54 (09) :730-736
[10]   Immense Essence of Excellence: Marine Microbial Bioactive Compounds [J].
Bhatnagar, Ira ;
Kim, Se-Kwon .
MARINE DRUGS, 2010, 8 (10) :2673-2701